A Cure In Sight
- Assets
- $197.4k
- Revenue
- $408.6k
- Investments
- $0.0
- Employees
- 1
- Location
- Raleigh, NC
- Founding
- 09/2014
- Data as of
- 12/2023
- EIN
- 46-1274306
Organization Overview
A Cure In Sight is located in Raleigh, NC. The organization was established in 2014. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. A Cure In Sight is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, A Cure In Sight generated $408.6k in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 16.1% each year . All expenses for the organization totaled $491.3k during the year ending 12/2023. While expenses have increased by 16.0% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
A CURE IN SIGHT'S MISSION IS TO PROVIDE FUNDING FOR PATIENT SERVICES FOR OCULAR MELANOMA EYE CANCER PATIENTS EDUCATION AWARENESS AND RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SUPPORT ONGOING RESEARCH FOR OCULAR MELANOMA.
ASSIST PATIENTS DURING FINANCIAL DIFFICULTIES.
EDUCATE THE PUBLIC AND PATIENT POPULATION OF OCULAR MELANOMA.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Melody King President | Officer | 10 | $0 |
Suzanne Luscure Secretary | Officer | 5 | $0 |
Marlene Day Treasurer | Officer | 5 | $0 |
Loren Seaman Vice President | Officer | 5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $320,038 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $320,038 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $88,480 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $32 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $408,550 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $88,407 |
| Grants and other assistance to domestic individuals. | $88,611 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $43,845 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $3,207 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $3,570 |
| Fees for services: Accounting | $6,855 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,284 |
| Advertising and promotion | $15,928 |
| Office expenses | $15,600 |
| Information technology | $10,127 |
| Royalties | $0 |
| Occupancy | $22,945 |
| Travel | $18,565 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,066 |
| All other expenses | $47,884 |
| Total functional expenses | $491,328 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $106,230 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $91,199 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $197,429 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $197,429 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $197,429 |
Grants Awarded
Over the last fiscal year, A Cure In Sight has awarded $133,010 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
TARGETED THERAPIES TECHNOLOGIES PURPOSE: Research | $123,000 |
BOARD OF TRUSTEES OF THE LELAND STA PURPOSE: Byers Eye research | $10,010 |